Citius Pharmaceuticals Inc CTXR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/29/24 EDT
0.70quote price arrow up+0.0031 (+0.448%)
Volume
44,643
Close
0.692UNCH (UNCH)
Volume
792,895
52 week range
0.60 - 1.56
Loading...
  • Open0.6751
  • Day High0.695
  • Day Low0.6603
  • Prev Close0.692
  • 52 Week High1.56
  • 52 Week High Date05/02/23
  • 52 Week Low0.60
  • 52 Week Low Date02/08/24

Key Stats

  • Market Cap110.094M
  • Shares Out159.09M
  • 10 Day Average Volume1.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-8.53

KEY STATS

  • Open0.6751
  • Day High0.695
  • Day Low0.6603
  • Prev Close0.692
  • 52 Week High1.56
  • 52 Week High Date05/02/23
  • 52 Week Low0.60
  • 52 Week Low Date02/08/24
  • Market Cap110.094M
  • Shares Out159.09M
  • 10 Day Average Volume1.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change-8.53

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-2.71
  • Fwd P/E (NTM)-4.46
  • EBITDA (TTM)-38.82M
  • ROE (TTM)-42.48%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Citius Pharmaceuticals Inc

 

Profile

MORE
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology, anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include LYMPHIR, Mino-Lok, Halo-Lido, NoveCite and Mino-Wrap. LYMPHIR is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok is an...
Leonard Mazur
Executive Chairman of the Board, Chief Executive Officer, Company Secretary
Myron Holubiak
Executive Vice Chairman of the Board
Jaime Bartushak
Chief Financial Officer, Chief Business Officer
Myron Czuczman M.D.
Chief Medical Officer, Executive Vice President
Ilanit Allen
Vice President - Corporate Communications and Investor Relations
Address
11 Commerce Dr Fl 1
Cranford, NJ
07016-3501
United States

Top Peers

SYMBOLLASTCHG%CHG
GLYC
GlycoMimetics Inc
1.55UNCHUNCH
RZLT
Rezolute Inc
2.61UNCHUNCH
LIFE
aTyr Pharma Inc
1.60UNCHUNCH
OTLK
Outlook Therapeutics Inc
9.10UNCHUNCH
ANIX
Anixa Biosciences Inc
3.02UNCHUNCH